Тромбитал Форте

Quick links

Choose a section

Quick links to important sections

Advertisements

Тромбитал Форте

Selected form

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Тромбитал Форте

To understand this medication, here is a quick overview of its core properties:

Property Description
Active Ingredients Acetylsalicylic Acid (АСК) (150 mg) and Magnesium Hydroxide (30.39 mg)
Form Film-coated tablets
Pharmacological Class Antiplatelet agent and Antacid combination
Common Use Long-term prevention of cardiovascular events
ATC Code B01AC30 (Inhibitors of platelet aggregation)

Тромбитал Форте is a fixed-dose combination drug primarily used in the management of cardiovascular health, specifically for secondary prevention. It is prescribed to patients at high risk of developing or recurring blood clots (thrombi), which can lead to serious conditions like a heart attack (myocardial infarction) or an ischemic stroke. The medicine is manufactured by STADA Arzneimittel AG and is typically available in tablet form.

This formulation is designed with two active components to address both therapeutic efficacy and safety. The drug's central ingredient is Acetylsalicylic Acid (АСК), dosed at 150 mg. АСК acts as an antiplatelet agent, preventing platelets from clumping together and forming clots inside blood vessels.

Its distinguishing component is Magnesium Hydroxide (Mg(OH)2), an antacid. This inclusion is a key feature that helps neutralize stomach acid, mitigating the potential for gastrointestinal irritation—a known side effect of long-term daily АСК use. This combination strategy is intended to enhance the benefit-risk profile for chronic use.

Advertisements

What side effects are possible with Тромбитал Форте?

Possible Side Effects and Safety Information

Тромбитал Форте contains Aspirin (Acetylsalicylic Acid) and Magnesium Hydroxide. As with any medication, side effects may occur, although not everyone experiences them. The inclusion of Magnesium Hydroxide is intended to help protect the gastrointestinal mucosa from the irritating effects of aspirin.


Gastrointestinal Side Effects (Most Common)

Since aspirin is a Nonsteroidal Anti-inflammatory Drug (NSAID) and an antiplatelet agent, the most commonly observed side effects are related to the gastrointestinal (GI) tract. These may include:

  • Stomach discomfort, heartburn, or nausea.
  • Increased risk of GI mucosal damage, potentially leading to gastric ulcers or bleeding (symptoms may include black, tarry stools, or vomiting blood that looks like coffee grounds). This risk is increased with higher doses and prolonged use.

Other Potential Side Effects

Other adverse effects associated with the components may include:

System Possible Side Effects
Hemorrhagic Easy bruising, prolonged bleeding time, nosebleeds
Hypersensitivity Allergic reactions (e.g., rash, hives) or, rarely, severe reactions (e.g., swelling of the face, difficulty breathing)
Neurological Tinnitus (ringing in the ears) or hearing impairment (especially with high doses)
Metabolic Diarrhea (associated with Magnesium Hydroxide)

Important Safety Information

Do not take Тромбитал Форте if you have a known allergy to salicylates or other NSAIDs, active bleeding (e.g., from a peptic ulcer), or a severe bleeding disorder. Exercise caution and consult a healthcare provider if you have a history of asthma, peptic ulcers, kidney disease, or liver disease.

Aspirin is generally not recommended for children and adolescents with viral infections due to the risk of Reye syndrome, a rare but serious condition. Always inform your doctor or pharmacist about all other medications, vitamins, or supplements you are taking, as drug interactions are possible. If you experience any signs of bleeding or a severe allergic reaction, seek immediate medical attention.

Advertisements

Overdose and Emergency Response

Overdose of Тромбитал Форте is defined by the toxicological profile of its Acetylsalicylic Acid (ASK) component, commonly known as salicylate poisoning, which can occur from a single large ingestion (acute) or chronic accumulation. Documented clinical manifestations of overdose may initially include tinnitus (ringing in the ears), hearing loss, nausea, vomiting, and hyperventilation (rapid or deep breathing). More severe presentations involve the central nervous system, including confusion, seizures, and coma. Life-threatening systemic complications documented in official sources include metabolic acidosis, pulmonary edema, acute renal failure, and gastrointestinal bleeding.

Regulatory bodies require that individuals seek immediate medical attention upon suspicion of an overdose. Emergency services must be contacted immediately if severe signs, such as collapse, difficulty breathing, or an unawakened state, are observed. Management is classified as symptomatic and supportive, as no specific antidote is known. Officially described supportive procedures include the administration of Activated Charcoal, intravenous fluid therapy, urine alkalinization with sodium bicarbonate, and Hemodialysis for severe cases.

Population-specific considerations include the increased risk of serious chronic toxicity in elderly patients due to reduced clearance, and the specific documented risk of Reye's Syndrome for pediatric patients following viral illness.

Advertisements

Therapeutic Uses of Тромбитал Форте

What Тромбитал Форте Treats: Main Uses and Benefits

The medication is applied across domains where additional symptomatic support is needed and is relevant in contexts marked by increased discomfort or tension. It is often used when symptoms intensify and supportive relief is needed, relevant for conditions presenting with systemic or localized discomfort, conditions characterized by periods of heightened symptoms, and conditions involving inflammatory or irritative processes. The active component is used in symptomatic management.


Supportive Management of Acute Symptomatic Discomfort

This domain may be part of symptomatic management across conditions presenting with symptoms related to physical discomfort that may appear suddenly or intensify over time. Тромбитал Форте may assist with easing the overall symptom load, and helps to ease the overall burden of symptoms. The medication is commonly used when symptoms create noticeable functional strain or interfere with daily functioning, and may be part of symptomatic management for symptoms associated with acute or disruptive episodes.

“Supports the patient during difficult episodes by easing distress.”


Assistance During Episodic Symptom Patterns

Тромбитал Форте is applied in addressing recurrent or episodic manifestations characterized by periods of increased physiological stress. This use is applied in contexts involving acute or unstable symptom patterns, and contributes to improved comfort during periods of heightened symptoms. The medication may help patients cope more steadily with symptom fluctuations, and assists with maintaining functional stability when symptoms are more noticeable.

Quick Fact: Symptomatic Relief Domains
May assist with symptoms that become more disruptive during flare-ups and provides supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview of Aspirin
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Тромбитал Форте — Official Regulatory Information

The eligibility to use Trombital Forte is strictly defined by regulatory documents, based on the official requirements for its active component, Acetylsalicylic Acid (Aspirin).

Eligibility Scope Official Regulatory Status
Populations Allowed Established for adults requiring secondary prevention of cardiovascular events (e.g., post-myocardial infarction or ischemic stroke).
Contraindicated Use is absolutely prohibited in patients with known hypersensitivity to Aspirin/NSAIDs, including Aspirin-sensitive asthma. It is also contraindicated in those with active pathological bleeding (e.g., hemorrhagic disorders), active peptic ulcer disease, or severe hepatic/renal impairment.
Pregnancy/Lactation Contraindicated in the third trimester of pregnancy. Use is not recommended while breastfeeding.
Age Restrictions Contraindicated in children and teenagers with or recovering from viral illnesses (e.g., flu, chickenpox) due to the risk of Reye’s syndrome. Caution is advised for adults ge 60 years due to increased risk of gastrointestinal bleeding.

Connection to the overall eligibility profile: Regulatory authorities define who can and cannot use the medicine by classifying certain conditions, such as active bleeding and severe organ failure, as absolute prohibitions. This structure ensures that eligibility is strictly limited to the target adult population for whom the cardiovascular benefits, as per regulatory documentation, outweigh the defined risks.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation defines this medicine's interaction profile based on the properties of its two active components: Acetylsalicylic Acid (AСК) and Magnesium Hydroxide. All interaction statements are derived strictly from official government labeling.

Pharmacodynamic and Pharmacokinetic Interactions

Interaction Type Interacting Substances/Conditions
Contraindicated Combination Methotrexate at high doses due to official documentation of inhibited renal clearance and enhanced toxicity.
Increased Bleeding Risk Co-administration with Anticoagulants, other Antiplatelet Agents, or Systemic Corticosteroids results in additive pharmacodynamic effects.
Exposure Modification AСК may alter the plasma levels of drugs like Phenytoin and Valproic Acid by competition for protein binding. Alkalinizing agents, including the Magnesium Hydroxide component, can decrease salicylate plasma levels by increasing renal clearance.
Interference AСК antagonizes the action of Uricosuric Agents; Ibuprofen can interfere with the anti-platelet effect of AСК.

Restrictions and Special Considerations

Official labeling includes specific restrictions to manage interaction risks. A mandatory timing separation rule is specified: AСК must be administered at least 2 hours or longer after ingesting Ibuprofen. Caution is required in patients with severe renal impairment due to the potential for increased risk of magnesium toxicity resulting from reduced elimination of the magnesium component. Heavy alcohol use (three or more drinks daily) is also associated with an increased risk of gastrointestinal bleeding.

Advertisements

Mechanism of Action

Irreversible Suppression of Platelet-Derived TXA2 Synthesis

This domain focuses on the primary antiplatelet component, Acetylsalicylic Acid (АСК), which exerts its effect by permanently inactivating the Cyclooxygenase-1 ( COX-1) enzyme within platelets . This molecular modification abolishes the platelet's capacity to generate the pro-thrombotic mediator Thromboxane A2 ( TXA2). This sustained suppression of the TXA2 pathway reduces platelet aggregation capacity, thereby altering the functional dynamics of the body's clotting pathways.


️ Complementary Modulation of the Gastric Chemical Environment

The second mechanistic domain involves Magnesium Hydroxide ( Mg( OH)2), which rapidly acts locally through chemical neutralization of stomach acid ( HCl). By elevating the local gastric pH, this component reduces the corrosive impact of acid and the antiplatelet agent itself on the stomach lining. This mechanism reduces the local impact of acid and АСК on gastric tissue, which facilitates sustained function of the primary enzymatic inhibitor.

Advertisements

Dosage and Administration Information

Official Administration and Dosing Principles

Тромбитал Форте is an antiplatelet agent combined with an antacid, formulated as a film-coated tablet for oral administration. The instructions for its use establish a standardized, once-daily regimen for chronic therapy, aligning with its function in secondary cardiovascular prevention.


Dosing and Frequency

Administration Scope Description
Route of Administration Oral administration (by mouth).
Standard Dosing Schedule One tablet daily, providing 150 mg of Acetylsalicylic Acid (АСК).
Frequency Pattern Once daily, intended for long-term, consistent application.
Dose Flexibility The regimen permits dose adjustment, including reduction of the daily AСК dose to 75 mg, based on medical necessity.

Procedural Instructions for Intake

The prescribing information contains specific instructions regarding the consumption of the tablet. The medicine is taken with water. The tablet is not required to be swallowed whole, as it may be chewed or crushed prior to intake. This flexibility is significant as it contrasts with the administration requirements of certain enteric-coated aspirin formulations, which must be swallowed intact.

Furthermore, in situations where a rapid initial antiplatelet effect is required, the first tablet administered may be chewed. The overall duration of this chronic therapy is determined by the patient's individual treatment plan as established by the prescribing physician, emphasizing the commitment to long-term use for its intended purpose.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Тромбитал Форте

Research into this medication was studied for two key areas: the long-standing evidence for its antiplatelet ingredient (Acetylsalicylic Acid, or AСК) in the research context of reducing cardiovascular events, and the research specific to the fixed combination (АСК plus Magnesium Hydroxide) regarding its absorption and GI outcomes. The evidence landscape is built on findings from large clinical trials and specialized studies designed for regulatory requirements.


Research Exploring Outcomes in Secondary Cardiovascular Prevention

Evidence for the AСК component was evaluated in large-scale meta-analyses and systematic reviews. These studies monitored adults with established conditions like prior heart attack or stroke. The key outcomes measured included the incidence of non-fatal heart attack, non-fatal stroke, and cardiovascular death. Research describes patterns observed in the studies over follow-up durations that often spanned several years. The evidence contributes to the broader evidence landscape.


Formulation Research and Evidence Gaps

Studies were conducted to examine outcomes linked to gastrointestinal discomfort associated with long-term, daily use of AСК. Comparative tolerability trials measured GI-related adverse events, and findings were mixed across studies.

Specialized Randomized Crossover Bioequivalence Studies were performed in healthy adult volunteers to ensure the combination product met regulatory absorption parameters. These findings apply only to the populations studied and do not provide context for long-term clinical effectiveness. Long-term outcomes for major clinical events are not fully established specifically for this exact combination tablet; data for certain groups, such as those with particular comorbid conditions, remain insufficient, and comparative evidence is lacking to show whether this specific combination offers a difference in long-term clinical outcomes.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Тромбитал Форте (FAQ)


Q: Does the magnesium in Тромбитал Форте completely prevent stomach irritation?

A: The magnesium component is added to neutralize stomach acid and reduce the potential for irritation from the aspirin component. While this helps mitigate the risk, official product information still lists stomach discomfort, ulcers, and bleeding as possible adverse events. The medicine's formulation is intended to reduce the potential for irritation, but official safety warnings still note that gastrointestinal adverse events are possible.

Q: How long does it typically take for the effects of the medicine to start working?

A: The antiplatelet effect of the aspirin component begins quickly due to its mechanism of action. Official information notes that a rapid initial antiplatelet effect is possible. The primary goal of the therapy is to maintain a long-lasting, sustained anti-clotting action over time.

Q: Are there any specific foods or drinks that should be avoided while taking this?

A: Regulatory documents strongly advise against heavy consumption of alcohol, as it is associated with an increased risk of gastrointestinal bleeding when combined with this type of medicine. Outside of this warning, there are no specific restrictions listed for common foods, and the medicine is intended to be taken with water.

Q: Can individuals with mild kidney or liver issues use Тромбитал Форте?

A: Official regulatory information states that the medicine is strictly prohibited for individuals with severe hepatic (liver) or renal (kidney) impairment. For those with milder pre-existing conditions, caution is typically advised. Official safety information indicates that caution and monitoring may be necessary for compromised organ function, particularly regarding the elimination of the magnesium component.

Q: What signs of a side effect should prompt a conversation with a healthcare provider?

A: Serious signs, such as any unusual bleeding, vomiting blood, or severe allergic reactions (like difficulty breathing or swelling), require immediate medical attention. Less severe but persistent effects, such as ongoing diarrhea, nausea, or tinnitus (ringing in the ears), are noted in official safety documents as effects that should be reported to a healthcare provider.

Q: If I am taking vitamins or mineral supplements, can they affect how this medicine works?

A: Regulatory documents state that it is important to disclose all medications, vitamins, and supplements to a healthcare provider. This is because interactions are possible; for example, the antacid component may affect how the body absorbs certain essential minerals like iron.

Q: How long does the anti-platelet effect of a single dose last?

A: The aspirin component works by permanently inactivating a key enzyme in blood platelets, which are the cells responsible for clotting. Because of this permanent action, the antiplatelet effect on each individual platelet lasts for its entire lifespan.

Q: Can this medication be used for general pain relief, or is it only for its main purpose?

A: Тромбитал Форте is officially indicated and prescribed for the long-term prevention of heart attack and stroke. Although aspirin is also an NSAID (a class of pain reliever), the medicine is officially indicated for the long-term prevention of cardiovascular events; general pain relief is not listed as an approved therapeutic use in the product's official labeling.

Q: Are there any long-term effects associated with using Тромбитал Форте for many years?

A: As this medicine is designed for long-term chronic use, the main long-term effects described in official safety information relate to the gastrointestinal system. These include the risk of chronic stomach damage, ulcers, and potential internal blood loss. Long-term use is associated with a risk of internal blood loss and iron deficiency anemia, which may necessitate monitoring.

Q: Why are pregnant individuals often asked to use this drug only under close supervision?

A: Official regulatory documents strictly prohibit the use of this medication during the third trimester of pregnancy. For the first two trimesters, use is generally not recommended unless a healthcare provider determines that the potential benefit to the mother outweighs the defined risks to the fetus. In these situations, the use requires close medical supervision as defined by regulatory guidance.

Q: Is the anti-platelet effect permanent, or does it stop once the drug is discontinued?

A: The action of aspirin is permanent on the individual platelets circulating in the blood at the time of intake. When the medicine is discontinued, the overall antiplatelet effect on the body gradually subsides. This reversal occurs as the body naturally produces new platelets that have not been affected by the medication.

Q: If I forget to take a dose, what is the general recommendation?

A: Instructions for chronic daily therapy describe the recommended actions for a missed dose, which includes general guidance on how long after the scheduled time a dose can be taken or when it should be skipped. These instructions are designed to avoid the accidental taking of a double dose.

Q: Does the medicine need to be taken with food, or can it be taken on an empty stomach?

A: Official instructions require the medicine to be taken by mouth with water. While the product label does not mandate taking it with food, taking it with or immediately following a meal is a common practice to help minimize the risk of stomach upset associated with aspirin.

Q: Is it possible to become dependent on Тромбитал Форте?

A: The active ingredients, Acetylsalicylic Acid (aspirin) and Magnesium Hydroxide, are not controlled substances. Official regulatory documents do not list either ingredient as having a potential for dependency or addiction.

Q: Does this medicine interact with herbal supplements like turmeric or ginkgo?

A: Official labeling advises informing a healthcare provider about all substances being taken. While specific herbs may not be named in the drug's label, the medicine carries a general warning about combining it with other substances that affect blood clotting. Any herbal product that affects blood clotting may present an interaction risk with the antiplatelet component.

Q: Are there known effects of the medication on vision or eye health?

A: While not commonly reported, safety information for the active components generally lists potential adverse effects by body system. Although eye problems are not frequently cited, related drug classes may list warnings about 'vision changes' that warrant reporting to a healthcare provider.

Q: Why might a person need to have regular blood tests while using this drug?

A: For individuals with existing kidney issues, regular blood tests may be necessary to monitor the level of magnesium in the body due to the antacid component. Additionally, monitoring for signs of iron deficiency anemia may be necessary due to the risk of occult blood loss associated with long-term aspirin use.

Q: Does this product affect blood pressure in any way?

A: The aspirin component belongs to a class of medicines (NSAIDs) for which official warnings may be present regarding fluid retention and effects on blood pressure control. Warnings for this drug class may necessitate caution in individuals with pre-existing conditions like hypertension or heart failure.

Q: Does the medicine lose its effectiveness over time with continuous use?

A: The medication is specifically prescribed for long-term, consistent application to achieve its preventive anti-clotting effect. Official regulatory information does not indicate that the medicine's effectiveness is known to decrease over time with continued, daily use.

Q: What should I do if I accidentally take two tablets at the same time?

A: Official safety information regarding accidental overdose states that contact with emergency medical services or a poison control center is necessary. Taking more than the prescribed amount can lead to potential toxicity.

Q: Does the medication cause any noticeable change in energy levels or mood?

A: Side effect profiles for the active ingredients sometimes list potential changes in mood or mental status, as well as unusual tiredness or drowsiness. These are adverse effects that should be reported to a healthcare provider if they occur.

Q: What are the regulatory classifications of this medicine (e.g., Prescription vs. OTC)?

A: Medicines containing aspirin and magnesium hydroxide can be found as both over-the-counter (OTC) and prescription products. The specific legal classification of this 150 mg aspirin dose product depends on regional regulatory rules and may be subject to stricter control than lower-dose alternatives.

Q: Does the magnesium in the pill provide any separate nutritional benefit?

A: The magnesium hydroxide component is included in this formulation solely for its functional purpose as an antacid—it chemically neutralizes stomach acid to reduce irritation. Its regulatory purpose is not defined as providing separate nutritional benefit to the user.

Advertisements

How should Тромбитал Форте be stored and disposed of?

Storage and Disposal Requirements

Official labeling defines specific conditions for storing and disposing of Тромбитал Форте (Acetylsalicylic Acid and Magnesium Hydroxide) to ensure product stability and safety.

Storage Conditions

The medication must be stored in a dry place at a temperature not exceeding 25 C. The product must be protected from light and must be kept in its original container, which should be tightly closed.

For child safety, the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Тромбитал Форте must not be discarded via wastewater or household waste. Patients are instructed to consult their pharmacist to learn the correct, environment-friendly procedure for disposal, as required by regulatory guidelines.

Constraint Requirement
Max Temperature Not exceeding 25 C
Container Rule Keep tightly closed
Disposal Rule Consult pharmacist

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Тромбитал Форте found in:

A-Z Index: